The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
that was a paper that showed that the strength of vaccination in healthy subjects who were I believe about age 65 could be augmented by basically a rapamycin analogue which again is counterintuitive right that's the adaptive immune system getting better with rapamycin very counterintuitive because of course rapamycin zon label use is specifically to suppress the adaptive immune system
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
the wrapalongs didn't shift any of the subsets very much except there was about a 20 a 25 to 30 percent decrease in the pd1 positive cd4 and cd8 these are the exhausted t cells that accumulate with age
boost in response to the vaccine as measured by antibody tighters so that supported the idea that similar to what had been shown in mice you could in fact to some extent rejuvenate the ability of the Aged immune system in humans to respond to a vaccine um with transient dosing with a Romy derivative ever in this case